In summary, our results suggest variant alleles of the genes involved in aspirin pathways, CYP2C9, ODC1 and UGT1A6, may be involved in the modification of CRC or colon cancer risk independently or in conjunction with aspirin use. Here, CYP2C9 is linked to malignant colon neoplasm.